← Eichor
Study identifier: NCT07030257 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Condition: Solid Tumor Malignancies · Colorectal Carcinoma · Small Cell Lung Cancer ( SCLC )  ·  Sponsor: Tasca Therapeutics

PhasePhase 1/Phase 2
Planned participants150
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383. The main questions if aims to answer are: * Does CP-383 slow or stop the growth of cancer in patients with advanced cancer * What medical problems do participants have when taking CP-383 Researchers will test CP-383 in all kinds of cancers at various dose levels to determine what the best dose is to study further. Researchers will also see if certain cancers that have gene mutations respond better to CP-383 Participants will: * Take CP-383 every day by mouth until the researcher learns whether CP-383 is helping slow or reduce the cancer growth * Visit the clinic weekly for the first 6 weeks for checkups and tests * Visit the clinic every 3 weeks thereafter for checkups and tests

This description comes directly from the study's public registry record.

Talk to the study team

Tasca Therapeutics  ·  617-430-7109  ·  trials@tascatx.com

Always discuss trial participation with your own doctor first.

Locations (13)

Sarah Cannon Research Institute at HealthONEDenver, Colorado, United StatesRecruiting
Florida Cancer Specialists-Lake NonaOrlando, Florida, United StatesRecruiting
START MidwestGrand Rapids, Michigan, United StatesRecruiting
Washington UniversitySt Louis, Missouri, United StatesRecruiting
Nebraska Cancer SpecialistsOmaha, Nebraska, United StatesRecruiting
Carolina BioOncology InstituteHuntersville, North Carolina, United StatesRecruiting
Cleveland ClinicCleveland, Ohio, United StatesRecruiting
Taylor Cancer Research CenterMaumee, Ohio, United StatesRecruiting
University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesRecruiting
NEXT Oncology - DallasDallas, Texas, United StatesRecruiting
START San AntonioSan Antonio, Texas, United StatesRecruiting
START Mountain RegionWest Valley City, Utah, United StatesRecruiting

+ 1 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07030257